Schedule of Research and Development Expenses (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Research and development expense	$ 607	$ 1,437	$ 2,861	$ 4,533
Amarex Clinical Research LLC [Member]
Research and development expense	3	157	207	337
Amarex Clinical Research LLC [Member] \| Pancreatic Cancer [Member]
Research and development expense	3	129	199	141
Amarex Clinical Research LLC [Member] \| Post COVID Conditions [Member]
Research and development expense		28	8	196
Jubilant HollisterStier [Member]
Research and development expense				1
Sterling Pharma Solutions [Member]
Research and development expense		133		262
Erasmus [Member]
Research and development expense				79
Azenova Sales International [Member]
Research and development expense		50		230
Alcami [Member]
Research and development expense	5		10	14
Clinical Studies [Member]
Research and development expense	309	582	1,636	1,880
Manufacturing and Engineering [Member]
Research and development expense	57	306	381	882
Quality Control [Member]
Research and development expense	221	398	685	1,232
Regulatory [Member]
Research and development expense	$ 20	$ 151	$ 159	$ 539